Go back

Opportunity profile: NIHR opens its arms to better trial design

The NIHR’s Efficacy and Mechanism Evaluation programme is looking for more efficient and innovative ways of testing drug efficacy than standard two-arm randomised trials. Lisa Douet, NIHR senior research fellow, gives Lila Randall the lowdown.

The National Institute of Health Research supports early clinical studies to establish the efficacy  of clinical intervention—following early proof-of-concept studies—through its Efficacy and Mechanism Evaluation programme.

The programme also supports studies that, in addition to testing efficacy, investigate the mechanism of action of the interventions in question. It is interested in increasing the efficiency of such clinical work.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.